Diiodohydroxyquinoline: Difference between revisions

Jump to navigation Jump to search
WikiBot (talk | contribs)
m Protected "Diiodohydroxyquinoline": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))
 
Aparna Vuppala (talk | contribs)
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Chembox new
{{chembox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 444779295
|ImageFile=Iodoquinol.png
|ImageFile=Iodoquinol.png
|ImageSize=150px
|ImageSize=150px
|ImageAlt=Skeletal formula of diiodohydroxyquinoline
|ImageFile1=Iodoquinol0.png
|ImageSize1=160
|ImageAlt1=Ball-and-stick model of the diiodohydroxyquinoline molecule
|IUPACName=5,7-diiodoquinolin-8-ol
|IUPACName=5,7-diiodoquinolin-8-ol
|OtherNames=
|OtherNames= Diquinol, [[iodoxin]], diiodoquin, amebaquin
|Section1= {{Chembox Identifiers
|Section1= {{Chembox Identifiers
|  CASNo=83-73-8
CASNo_Ref = {{cascite|correct|??}}
| PubChem=3728
| CASNo=83-73-8
| SMILES=C1=CC2=C(C(=C(C=C2I)I)O)N=C1
| PubChem=3728
|  MeSHName=Iodoquinol
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 86754
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00581
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 63W7IE88K8
| SMILES=C1=CC2=C(C(=C(C=C2I)I)O)N=C1
ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 3597
|  InChI = 1/C9H5I2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H
|  InChIKey = UXZFQZANDVDGMM-UHFFFAOYAF
|  StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C9H5I2NO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H
|  StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = UXZFQZANDVDGMM-UHFFFAOYSA-N
| MeSHName=Iodoquinol
| ATCCode_prefix = G01
| ATCCode_suffix = AC01
   }}
   }}
|Section2= {{Chembox Properties
|Section2= {{Chembox Properties
Line 25: Line 49:
   }}
   }}
}}
}}
__NOTOC__
{{SI}}
{{CMG}}
==Overview==
The [[quinoline]] derivative '''diiodohydroxyquinoline''' ([[International Nonproprietary Name|INN]]) or '''iodoquinol''' ([[United States Adopted Name|USAN]]), can be used in the treatment of [[amoebiasis]].
It is poorly absorbed from the [[gastrointestinal tract]] and is used as a luminal amebicide. It acts by [[chelation]] of [[ferrous ion]]s essential for metabolism.
It was discovered by Adco Co. and introduced as ''diiodohydroxyquinoline''.
Susceptibility of ''[[Dientamoeba fragilis]]'' has been measured.
Iodoquinol is an amebocide used against ''[[Entamoeba histolytica]]'', and it is active against both cysts and trophozoites that are localized in the lumen of the intestine. It is considered the drug of choice for treating asymptomatic or moderate forms of amebiasis. The mechanism of action is unknown. Iodoquinol is used for diseases caused by moderate intestinal amebiasis.


'''Diiodohydroxyquinoline''' ([[International Nonproprietary Name|INN]]) or '''iodoquinol''' ([[United States Adopted Name|USAN]]), widely known by the trade name '''Diodoquin''', is a [[quinoline]] derivative which can be used in the treatment of [[amoebiasis]].
==References==
 
{{reflist|2}}
{{Agents against amoebiasis and other protozoal diseases}}
{{biochem-stub}}


[[Category:Organoiodides]]
[[Category:Organoiodides]]
[[Category:Quinolines]]
[[Category:Drug]]

Latest revision as of 13:39, 9 April 2015

Template:Chembox E number
Diiodohydroxyquinoline
Skeletal formula of diiodohydroxyquinoline
Ball-and-stick model of the diiodohydroxyquinoline molecule
Names
IUPAC name
5,7-diiodoquinolin-8-ol
Other names
Diquinol, iodoxin, diiodoquin, amebaquin
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
ECHA InfoCard Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
KEGG
MeSH Iodoquinol
UNII
Properties
C9H5I2NO
Molar mass 396.951
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is ☑Y☒N ?)
Infobox references

WikiDoc Resources for Diiodohydroxyquinoline

Articles

Most recent articles on Diiodohydroxyquinoline

Most cited articles on Diiodohydroxyquinoline

Review articles on Diiodohydroxyquinoline

Articles on Diiodohydroxyquinoline in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Diiodohydroxyquinoline

Images of Diiodohydroxyquinoline

Photos of Diiodohydroxyquinoline

Podcasts & MP3s on Diiodohydroxyquinoline

Videos on Diiodohydroxyquinoline

Evidence Based Medicine

Cochrane Collaboration on Diiodohydroxyquinoline

Bandolier on Diiodohydroxyquinoline

TRIP on Diiodohydroxyquinoline

Clinical Trials

Ongoing Trials on Diiodohydroxyquinoline at Clinical Trials.gov

Trial results on Diiodohydroxyquinoline

Clinical Trials on Diiodohydroxyquinoline at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Diiodohydroxyquinoline

NICE Guidance on Diiodohydroxyquinoline

NHS PRODIGY Guidance

FDA on Diiodohydroxyquinoline

CDC on Diiodohydroxyquinoline

Books

Books on Diiodohydroxyquinoline

News

Diiodohydroxyquinoline in the news

Be alerted to news on Diiodohydroxyquinoline

News trends on Diiodohydroxyquinoline

Commentary

Blogs on Diiodohydroxyquinoline

Definitions

Definitions of Diiodohydroxyquinoline

Patient Resources / Community

Patient resources on Diiodohydroxyquinoline

Discussion groups on Diiodohydroxyquinoline

Patient Handouts on Diiodohydroxyquinoline

Directions to Hospitals Treating Diiodohydroxyquinoline

Risk calculators and risk factors for Diiodohydroxyquinoline

Healthcare Provider Resources

Symptoms of Diiodohydroxyquinoline

Causes & Risk Factors for Diiodohydroxyquinoline

Diagnostic studies for Diiodohydroxyquinoline

Treatment of Diiodohydroxyquinoline

Continuing Medical Education (CME)

CME Programs on Diiodohydroxyquinoline

International

Diiodohydroxyquinoline en Espanol

Diiodohydroxyquinoline en Francais

Business

Diiodohydroxyquinoline in the Marketplace

Patents on Diiodohydroxyquinoline

Experimental / Informatics

List of terms related to Diiodohydroxyquinoline

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The quinoline derivative diiodohydroxyquinoline (INN) or iodoquinol (USAN), can be used in the treatment of amoebiasis. It is poorly absorbed from the gastrointestinal tract and is used as a luminal amebicide. It acts by chelation of ferrous ions essential for metabolism. It was discovered by Adco Co. and introduced as diiodohydroxyquinoline. Susceptibility of Dientamoeba fragilis has been measured. Iodoquinol is an amebocide used against Entamoeba histolytica, and it is active against both cysts and trophozoites that are localized in the lumen of the intestine. It is considered the drug of choice for treating asymptomatic or moderate forms of amebiasis. The mechanism of action is unknown. Iodoquinol is used for diseases caused by moderate intestinal amebiasis.

References